Linical Co (TSE:2183) Total Receivables: 円1,739 Mil (As of Mar. 2026)


TSE:2183 Linical Co Ltd TSE:2183
48 GF Score
Price 円218.00
GF Value 円315.03
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co Total Receivables?

Linical Co TSE:2183 +0.46% 48 Total Receivables is 円1,739 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 48/100 and a GF Value™ of 円315.03 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's Total Receivables for the quarter that ended in Mar. 2026 was 円1,739 Mil.

Linical Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Linical Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Total Receivables Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,917.99 3,428.00 3,463.78 2,774.19 1,738.93

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,463.78 2,869.27 2,774.19 2,525.62 1,738.93
TSE:2183
48GF Score
Linical Co Ltd TSE:2183
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Linical Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of 円1,739 Mil mean?
Linical Co (TSE:2183) has a Total Receivables of 円1,739 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Linical Co and its competitors.
Is Linical Co's Total Receivables too high?
Linical Co's current Total Receivables is 円1,739 Mil. Overall, Linical Co has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Total Receivables compare to VRTX and REGN?
Linical Co's Total Receivables of 円1,739 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Linical Co and its competitors. Linical Co's current Total Receivables is 円1,739 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円315.03, compared to a current price of 円218.00 — trading 30.8% below its estimated fair value. The current Total Receivables is 円1,739 Mil. Linical Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Total Receivables is 円1,739 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円218.00 is trading 30.8% below its estimated GF Value™ of 円315.03. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • Total Receivables: 円1,739 Mil
  • GF Value™: 円315.03 vs. price of 円218.00 (30.8% below fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
48GF Score

Get the complete analysis for TSE:2183

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円218.00
Price
円315.03
GF Value